| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/23/1999 | CA2323633A1 Selection subtraction approach to gene identification |
| 09/23/1999 | CA2323604A1 Interferon alpha plasmids and delivery systems, and methods of making and using the same |
| 09/23/1999 | CA2323494A1 Gene encoding labyrinthin, a marker for cancer |
| 09/23/1999 | CA2323112A1 Multigene vectors |
| 09/23/1999 | CA2323110A1 Sequencing by hybridisation |
| 09/23/1999 | CA2323095A1 Metal-containing ribonucleotide polypeptides |
| 09/23/1999 | CA2323093A1 Compounds and methods for therapy and diagnosis of lung cancer |
| 09/23/1999 | CA2323083A1 Isolated mammalian membrane protein genes and related reagents |
| 09/23/1999 | CA2323078A1 Compositions for modulating cell differentiation comprising a lipid and a morphogen |
| 09/23/1999 | CA2323075A1 Method and device for detecting a nucleotide sequence |
| 09/23/1999 | CA2322781A1 Haloperoxidases with altered ph profiles |
| 09/23/1999 | CA2322660A1 Enhanced anti-tumor immunity |
| 09/23/1999 | CA2322659A1 Compositions and methods for gene-based vaccines to provoke t cell responses |
| 09/23/1999 | CA2322016A1 Genes encoding mlo proteins and conferring fungal resistance upon plants |
| 09/23/1999 | CA2321113A1 Anti-inositolphosphoglycan monoclonal antibodies |
| 09/23/1999 | CA2321091A1 An equine neospora isolate and its uses |
| 09/23/1999 | CA2319037A1 Identification of factors which mediate the interaction of heterotrimeric g proteins and monomeric g proteins |
| 09/23/1999 | CA2263784A1 Dual-tagged proteins and their uses |
| 09/23/1999 | CA2249662A1 Novel compounds |
| 09/22/1999 | EP0943688A2 Polypeptide of N-acetylglucosamine-6-0-sulfotransferase and DNA encoding the same |
| 09/22/1999 | EP0943687A2 Method of producing L-serine by fermentation |
| 09/22/1999 | EP0943686A2 Protein participating in activation of nitrile hydratase,gene,plasmid and a process for producing an amide |
| 09/22/1999 | EP0943685A2 G-protein coupled receptor from human brain |
| 09/22/1999 | EP0943684A2 Frizzled-like polypeptides and polynucleotides |
| 09/22/1999 | EP0943683A1 Human vanilloid receptor homologue Vanilrep1 |
| 09/22/1999 | EP0943682A1 Tumor suppressor gene del-27 and the protein coded thereby, methods of production and use thereof |
| 09/22/1999 | EP0943680A1 Suicide gene therapy system for the treatment of brain tumours |
| 09/22/1999 | EP0943679A1 Novel RNase-like protein and its use |
| 09/22/1999 | EP0943678A2 Lipase variants |
| 09/22/1999 | EP0943625A1 Antibodies, production method of the antibodies, hybridomas which produce the antibodies, production method of the hybridomas and antigen proteins recognized by the antibodies |
| 09/22/1999 | EP0943323A1 Cosmetic or dermatological composition containing at least a natural or recombinant arachnida silk protein or an analogue |
| 09/22/1999 | EP0943158A2 Affinity based self-assembly systems and devices for photonic and electronic applications |
| 09/22/1999 | EP0943097A1 METHOD TO DETECT IgE |
| 09/22/1999 | EP0943096A1 A PROTEIN PREPARATION THAT MEDIATES Ca2+ -DEPENDENT TRANSBILAYER MOVEMENT OF PLASMA MEMBRANE PHOSPHOLIPID AND INHIBITORS THEREOF |
| 09/22/1999 | EP0943019A1 Sets of labeled energy transfer fluorescent primers and their use in multi component analysis |
| 09/22/1999 | EP0943018A2 Male infertility y-deletion detection battery |
| 09/22/1999 | EP0943017A1 Diagnostic assay for breast cancer susceptibility |
| 09/22/1999 | EP0943016A1 Method for identifying mutants and molecules |
| 09/22/1999 | EP0943015A2 Method and apparatus for preparing sample cartridges for a particle acceleration device |
| 09/22/1999 | EP0943014A1 Methods for diagnosing glaucoma and discovering anti-glaucoma drugs |
| 09/22/1999 | EP0943013A2 Detection of chromosomal abnormalities |
| 09/22/1999 | EP0943012A1 Identification of molecular sequence signatures and methods involving the same |
| 09/22/1999 | EP0943009A2 Species-specific, genus-specific and universal dna probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories |
| 09/22/1999 | EP0943005A1 Tissue specific and target rna-specific ribozymes as antimicrobial therapeutics against microbial pathogens |
| 09/22/1999 | EP0943004A2 Post-mitotic neurons containing adenovirus vectors that modulate apoptosis and growth |
| 09/22/1999 | EP0943003A1 Insulin-like growth factor i (igf-i) expression system and methods of use |
| 09/22/1999 | EP0943002A2 How to affect the chlorophyll biosynthesis in plants |
| 09/22/1999 | EP0943001A1 Heat stable mutants of starch biosynthesis enzymes |
| 09/22/1999 | EP0943000A1 A small volume, highly sensitive method for detecting environmental insults |
| 09/22/1999 | EP0942999A1 Gene trap construct for identification and isolation of genes |
| 09/22/1999 | EP0942998A1 Notch |
| 09/22/1999 | EP0942995A1 Novel calpaines, production and use thereof |
| 09/22/1999 | EP0942994A1 H mutant alpha-amylase enzymes |
| 09/22/1999 | EP0942993A2 Phytase from germinated soybeans |
| 09/22/1999 | EP0942992A1 O-fucosyltransferase |
| 09/22/1999 | EP0942991A2 Identification of inhibitors that prevent access of telomerase to chromosomal terminus |
| 09/22/1999 | EP0942990A2 P70-s6k or related kinase with constitutive activity |
| 09/22/1999 | EP0942989A1 Method for the production of 1,3-propanediol by recombinant organisms |
| 09/22/1999 | EP0942988A1 Hiv envelope polypeptides and vaccine |
| 09/22/1999 | EP0942987A1 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes |
| 09/22/1999 | EP0942986A1 Systems for determining substances active against hpv-associated diseases |
| 09/22/1999 | EP0942985A1 Broad-spectrum delta-endotoxins |
| 09/22/1999 | EP0942984A2 C3 BINDING PROTEIN OF $i(STREPTOCOCCUS PNEUMONIAE) |
| 09/22/1999 | EP0942983A2 $i(STREPTOCOCCUS PNEUMONIAE) ANTIGENS AND VACCINES |
| 09/22/1999 | EP0942982A1 Bacterial elastin binding protein, nucleic acid sequence encoding same and diagnostic and therapeutic methods of use thereof |
| 09/22/1999 | EP0942981A1 Fibroblast growth factor-13 |
| 09/22/1999 | EP0942980A1 Tumor-associated kazal inhibitor with pec-60 homology |
| 09/22/1999 | EP0942979A2 Il-9 receptor variants, useful in treating and diagnosing atopic allergies including asthma and related disorders |
| 09/22/1999 | EP0942978A2 Methods for producing the anaphase promoting complex |
| 09/22/1999 | EP0942977A2 Nucleic acid encoding schwannomin-binding-proteins and products related thereto |
| 09/22/1999 | EP0942976A1 Human sqm1 protein homolog comprising a cell adhesion protein |
| 09/22/1999 | EP0942975A1 Glaucoma-associated protein and corresponding nucleic acid and their therapeutic and diagnostic uses |
| 09/22/1999 | EP0942974A2 Secreted proteins and polynucleotides encoding them |
| 09/22/1999 | EP0942973A1 Mutants of the lag-3 proteins, products for the expression of these mutants and use |
| 09/22/1999 | EP0942972A2 E25a PROTEIN, METHODS FOR PRODUCTION AND USE THEREOF |
| 09/22/1999 | EP0942971A2 Method for altering the nutritional content of plant seed |
| 09/22/1999 | EP0942970A1 Novel carboxylesterase nucleic acid molecules, proteins and uses thereof |
| 09/22/1999 | EP0942969A1 Method for identifying translationally regulated genes |
| 09/22/1999 | EP0942968A2 TRANSGENIC MAMMALS HAVING HUMAN IG LOCI INCLUDING PLURAL V H? AND V$g(k) REGIONS AND ANTIBODIES PRODUCED THEREFROM |
| 09/22/1999 | EP0942967A1 Transgenic animal expressing a syndecan in the regions of hypothalamus |
| 09/22/1999 | EP0942965A2 Novel genes coding for amino acid deacetylases with specificity for n-acetyl-l-phosphinothricin, their isolation and their use |
| 09/22/1999 | EP0942964A2 Thermostable polymerases having altered fidelity |
| 09/22/1999 | EP0942963A1 Improved nucleic acids for reducing carbohydrate epitopes |
| 09/22/1999 | EP0942959A1 Transgenic non-human animals capable of producing heterologous antibodies |
| 09/22/1999 | EP0942934A2 Receptor tyrosine kinase genes |
| 09/22/1999 | EP0942933A1 Human kdel receptor |
| 09/22/1999 | EP0942929A1 Dna encoding lepidopteran-active delta-endotoxins and its use |
| 09/22/1999 | EP0942928A1 Subunit respiratory syncytial virus vaccine preparation |
| 09/22/1999 | EP0942926A2 DISRUPTION OF THE MAMMALIAN Rad51 PROTEIN AND DISRUPTION OF PROTEINS THAT ASSOCIATE WITH MAMMALIAN Rad51 FOR HINDERING CELL PROLIFERATION |
| 09/22/1999 | EP0942917A1 Stable compositions for nucleic acid amplification and sequencing |
| 09/22/1999 | EP0942901A1 Cyclic imines as pesticides |
| 09/22/1999 | EP0942758A2 Compounds with improved inductive effect on cartilage and bones |
| 09/22/1999 | EP0942755A2 Treatment of diabetes with transcription factor gene |
| 09/22/1999 | EP0673387B1 Materials and methods for control of pests |
| 09/22/1999 | EP0620741B1 Cytotoxic drug therapy |
| 09/22/1999 | EP0594743B1 Continuous cell line and vaccine against avian coccidia |
| 09/22/1999 | EP0540525B1 Method of preparation of vaccines, and the use of the vaccines thus prepared |
| 09/22/1999 | EP0449948B1 Grafting genetically modified cells to treat diseases of the central nervous system |
| 09/22/1999 | CN1229439A Fusion polypeptides comprising an IgE-binding domain and a HSA component, and their diagnostic and therapeutic uses |
| 09/22/1999 | CN1229438A Erythromycins and process for their preparation |